Borna Mehrad, MD

Borna Mehrad, MD

Borna Mehrad, MD
Ethel Smith Research Professor and Chief

Division Chief, Division of Pulmonary, Critical Care and Sleep Medicine

Email: Emma Dyer
TEL:  Patient– 352.273.8740  Admin- 352.273.8738

UF Health Pulmonary – Medical Specialties – Medical Plaza




MDUniversity of Nottingham, United KingdomMedicine
ResidencyThomas Jefferson University Hospital & University of Texas SouthwesternInternal Medicine
 Fellowship University of Texas Southwestern Infectious Disease
FellowshipUniversity of Michigan Medical CenterPulmonary & Critical Care Medicine
FellowshipSchering-Plough Research InstitutePost-doctoral Research


  • Pulmonary Diseases
  • Critical Care

Clinical Interests:

  • Interstitial Lung Disease (ILD)

Board Certifications:

  • Pulmonary Medicine
  • Critical Care Medicine

Grant Support:

  • American Heart Association Transformational Project Award (18TPA34170486), “Circulating fibrocytes as biomarkers of cardiac sarcoidosis,” Borna Mehrad, Principle Investigator; 7/1/2018-6/30/2021, annual direct costs $100,000.
  • NIH/NIBIB, UOIEB024501, Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens; 2017-22.
  • NIH/NIAID, ROIAI135128, Multi scale modeling of the battle our iron in invasive lung infection.


  • Methods for treating and diagnosing fibrotic and fibroproliferative diseases. United States Patent No. 8216796 B2
  • Compositions and methods for using and identifying antimicrobial agents. United States Patent No. 20160271220 A1.

Honors and Awards:

  • Trainee Investigator Award, American Federation for Medical Research, 1999
  • Department of Medicine Outstanding Teaching Award, UT Southwestern Medical Center, 2002
  • Department of Medicine Mentorship Award, University of Virginia, 2012/2014
  • Department of Medicine Research Award, University of Virginia, 2013
  • American Society of Clinical Investigation, 2013
  • Fellow of the American College of Chest Physicians, 2015
  • Voted “Attending of the Year” by Internal Medicine Housestaff, University of Virginia, 2016
  • “America’s Top Doctors” in Pulmonary Disease, Castle Connolly, Ltd., 2015-2017


  • Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK, Kim K, Burdick MD, Strieter RM, Mehrad B. Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med. 2014; 190(12):1395-401. PMCID: PMC4299649
  • Mehrad B, Clark NM, Zhanel GG, Lynch JP 3rd. Antimicrobial resistance in hospital-acquired Gram-negative bacterial infections. Chest 2015; 147(5):1413-21. PMCID: PMC4420185.
  • Michels K, Nemeth E, Ganz T, Mehrad B. The role of hepcidin in host defense against infectious diseases. PLoS Pathogens 2015;11(8):e1004998. PMCID: PMC4546197
  • Oremland M, Michels K, Bettina A, Lawrence C, Mehrad B, Laubenbacher R. Computational model of invasive aspergillosis in the lung. BMC Syst Biol. 2016; 10(1):34. doi: 10.1186/s12918-016-0275-2. PMCID: PMC4839115
  • Keeley EC, Marinescu MA, Burdick MD, Strieter RM, Mehrad B. Circulating fibrocytes as predictors of adverse events in unstable angina. Transl Res 2016;172:73-83.e1. doi: 10.1016/j.trsl.2016.02.013. PMCID: PMC4866880
  • Bettina A, Zhang Z, Michels K, Cagnina RE, Vincent I, Burdick MD, Kadl A, Mehrad B. M-CSF mediates host defense during bacterial pneumonia by promoting the survival of lung and liver mononuclear phagocytes. J Immunol. 2016;196(12):5047-55. PMCID: PMC4893984
  • Gomez DC, Mehrad B. Eosinophilic pneumonia associated with pirfenidone therapy. Eur Respir J. 2016. 48(4):1240-1242. PMCID: in process.
  • Michels K, Zhang Z, Bettina A, Cagnina RE, Stefanova D, Burdick MD, Nemeth E, Ganz T, Mehrad B. 2017. Hepcidin-mediated iron sequestration is required for host defense against pneumonia. JCI Insight. 2017;2(6): e92002. PMCID: PMC5358492
  • Complete list of publications: